Results 281 to 290 of about 13,881 (340)

Multisite clinical cross-validation and variant interpretation of a next generation sequencing panel for lymphoid cancer prognostication. [PDF]

open access: yesJ Clin Pathol
Sabatini PJB   +11 more
europepmc   +1 more source

Cryopreservation practices in clinical and preclinical iPSC‐based cell therapies: Current challenges and future directions

open access: yesBiotechnology Progress, EarlyView.
Abstract Induced pluripotent stem cells (iPSCs) offer significant therapeutic potential, but cryopreservation challenges, particularly the reliance on cytotoxic Dimethyl Sulfoxide (Me2SO), hinder their clinical application. This review examines current cryopreservation practices in clinical and preclinical iPSC‐based therapies, highlighting the ...
Michael Dobruskin   +2 more
wiley   +1 more source

Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities

open access: yesCancer Communications, EarlyView.
Abstract Copper, one of the essential nutrients for the human body, acts as an electron relay in multiple pathways due to its redox properties. Both deficiencies and excesses of copper lead to cellular fragility. Therefore, it can manifest pro‐ and anti‐cancer properties in tumors. Therefore, it is crucial to clarify the copper activity within the cell.
Dan Shan   +13 more
wiley   +1 more source

Paediatric bone marrow mesenchymal stem cells support acute myeloid leukaemia cell survival and enhance chemoresistance via contact-independent mechanism. [PDF]

open access: yesBr J Haematol
Laing A   +11 more
europepmc   +1 more source

A case of anti-CD320 antibody-positive cutaneous arteritis accompanied by multiple cranial nerve symptoms. [PDF]

open access: yesRheumatology (Oxford)
Hasegawa A   +6 more
europepmc   +1 more source

Mutational cooperativity of RUNX1::RUNX1T1 isoform 9a and oncogenic NRAS in zebrafish myeloid leukaemia. [PDF]

open access: yesBiol Open
Lints R   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy